Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports

  • 📰 Reuters
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 97%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion in a deal that would further expand Gilead's portfolio of cancer treatments, the Wall Street Journal reported on Saturday.

FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease , during the outbreak of the coronavirus disease , in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake

A deal for Immunomedics, whose cancer therapy Trodelvy is FDA-approved as a third-line treatment for an aggressive type of breast cancer called Metastatic Triple-Negative Breast Cancer, could be announced Monday if not sooner, the Journal said, citing people familiar with the matter.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Under his 👁

Isn’t gilead the town/state or what ever in handmaids tale?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reportsGilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion in a deal that would further expand Gilead's portfolio of cancer treatments, the Wall Street Journal reported on Saturday. Under his eye
Source: Reuters - 🏆 2. / 97 Read more »

Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reportsGilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion in a deal that would further expand Gilead's portfolio of cancer treatments, the Wall Street Journal reported on Saturday. Under his eye
Source: Reuters - 🏆 2. / 97 Read more »

Nvidia nears deal to buy chip designer Arm for more than $40 billion - sourcesNvidia Corp is close to a deal to buy British chip designer Arm Holdings from SoftBank Group Corp for more than $40 billion in a deal which would create a giant in the chip industry, according to two people familiar with the matter. fuck the earth debasing Nvidia Lame
Source: Reuters - 🏆 2. / 97 Read more »

Nvidia nears deal to buy chip designer Arm for more than $40 billion - sourcesNvidia Corp is close to a deal to buy British chip designer Arm Holdings from SoftBank Group Corp for more than $40 billion in a deal which would create a giant in the chip industry, according to two people familiar with the matter. that guy with a camera tho, get those shots man That's ... A lot of money.
Source: Reuters - 🏆 2. / 97 Read more »